Drug Type Small molecule drug |
Synonyms KUR 213 |
Target |
Action agonists |
Mechanism PDGFR agonists(Platelet-derived growth factor receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Wounds and Injuries | Phase 1 | Switzerland | - |